rdf:type |
|
lifeskim:mentions |
umls-concept:C0017431,
umls-concept:C0019704,
umls-concept:C0205466,
umls-concept:C0449820,
umls-concept:C0459471,
umls-concept:C0470187,
umls-concept:C0683598,
umls-concept:C0871261,
umls-concept:C1435444,
umls-concept:C1519941,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
4
|
pubmed:dateCreated |
2011-6-20
|
pubmed:abstractText |
There is not yet consensus on interpretation of genotypic HIV-1 resistance to darunavir (DRV). We validated existing rules and a newly derived score.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
2040-2058
|
pubmed:author |
pubmed-author:ARCA study group,
pubmed-author:AntinoriAndreaA,
pubmed-author:BaldantiFaustoF,
pubmed-author:De LucaAndreaA,
pubmed-author:Di GiambenedettoSimonaS,
pubmed-author:Di PerriGiovanniG,
pubmed-author:GianottiNicolaN,
pubmed-author:MaseratiRenatoR,
pubmed-author:MicheliValeriaV,
pubmed-author:NarcisoPasqualeP,
pubmed-author:PernoCarlo FCF,
pubmed-author:ProsperiMattia C FMC,
pubmed-author:SantoroMaria MMM,
pubmed-author:TMC114-C226 study group,
pubmed-author:ZazziMaurizioM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
489-97
|
pubmed:meshHeading |
pubmed-meshheading:21685536-Algorithms,
pubmed-meshheading:21685536-Anti-HIV Agents,
pubmed-meshheading:21685536-Drug Resistance, Viral,
pubmed-meshheading:21685536-Drug Therapy, Combination,
pubmed-meshheading:21685536-Genotype,
pubmed-meshheading:21685536-HIV Infections,
pubmed-meshheading:21685536-HIV Protease Inhibitors,
pubmed-meshheading:21685536-HIV-1,
pubmed-meshheading:21685536-Humans,
pubmed-meshheading:21685536-Microbial Sensitivity Tests,
pubmed-meshheading:21685536-Predictive Value of Tests,
pubmed-meshheading:21685536-Ritonavir,
pubmed-meshheading:21685536-Sulfonamides,
pubmed-meshheading:21685536-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score.
|
pubmed:affiliation |
Institute of Clinical Infectious Diseases, Catholic University, Rome, Italy. andrea.deluca@rm.unicatt.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|